Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
4 For example, ADA and KDIGO joint group has recommended that for patients with T2DM and CKD who do not achieve their glycemic target with metformin and/or an SGLT2i or cannot use them, a GLP-1RAs with proven cardiovascular benefit is recommended
Yes, blood work is required to ensure youre healthy enough to begin the treatment
Product Details Active Ingredient : Bremelanotide (PT-141) Concentration : 20 mg per vial (lyophilized powder) Administration : Subcutaneous injection after reconstitution Volume : Reconstituted per provider instruction (typically 12 mL bacteriostatic water) Use : For clinical and research use under medical supervision Storage : Store lyophilized powder at 28C (3646F)
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
Food & Drug Administration (FDA) has approved many drugs in this class over the past couple of years including Ozempic, Wegovy, Mounjaro, and Zepbound to name a few
US$ 22.29
US$ 23.65
US$ 29.78
US$ 26.98
US$ 23.12
US$ 26.84
US$ 23.00
